aprepitant 165 mg

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chemotherapy-Induced Nausea and VomitingChemotherapy-Induced Nausea and Vomiting (CINV)

Phase 1

A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)

CompletedNCT00945321

Merck Sharp & Dohme LLCChemotherapy-Induced Nausea and Vomiting

Start: 2009-02-28End: 2009-03-31Updated: 2015-01-28

Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)

CompletedNCT01111851

Merck Sharp & Dohme LLCChemotherapy-Induced Nausea and Vomiting (CINV)

Start: 2010-04-30End: 2010-10-31Updated: 2015-02-25